A double blind clinical evaluation of a phenylpropanolamine-caffeine-vitamine combination and a placebo in the treatment of exogenous obesity.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002110:Caffeine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy*; D010665:Phenylpropanolamine / Q000627:therapeutic use*; D010919:Placebos; D014815:Vitamins / Q000627:therapeutic use*
D004338:Drug Combinations; D010919:Placebos; D014815:Vitamins; D010665:Phenylpropanolamine; D002110:Caffeine